A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care

CompletedOBSERVATIONAL
Enrollment

195

Participants

Timeline

Start Date

August 17, 2021

Primary Completion Date

September 16, 2021

Study Completion Date

September 16, 2021

Conditions
SARS (Severe Acute Respiratory Syndrome)Covid19
Interventions
DIAGNOSTIC_TEST

The Pine Trees Health Test System

Consists of the Pine Trees Health Reader and the Pine Trees Health COVID-19 Test Kit, which contains the Pine Trees Health Cartridge, Pine Trees Health Sample Vial containing Sample Lysis Buffer and the Pine Trees Health Nasal Swab (anterior nares) for collection. The Test System is a point-of-care test used for the qualitative detection of nucleic acid from SARS-CoV-2 viral RNA in nasal swabs taken from individuals who are suspected by a healthcare professional of having COVID-19. The COVID-19 test is a rapid molecular, in vitro diagnostic test using isothermal nucleic acid amplification technology and detection of the resulting amplicon using CRISPR-mediated collateral reporter unlocking.

Trial Locations (3)

28625

PMG Research of Piedmont Healthcare, Statesville

34609

ASCLEPES Research Center, Spring Hill

98052

Eastside Research Associates, Redmond

All Listed Sponsors
collaborator

Eastside Research Associates

UNKNOWN

collaborator

ICON plc

INDUSTRY

collaborator

ASCLEPES Research Center

UNKNOWN

collaborator

DuPage Medical Group

OTHER

collaborator

MRI Global

INDUSTRY

collaborator

Piedmont Healthcare

OTHER

lead

Pine Trees, Inc.

INDUSTRY